You are here: Industry Insights > vaccine

News List

Novavax starts animal testing of coronavirus vaccine candidates pharmaceutical-technology
March 03, 2020
US-based biotechnology company Novavax has begun testing its new coronavirus vaccine candidates in animal models.
Novavax Advances Development of COVID-19 Vaccine contractpharma
March 03, 2020
Novavax, Inc., a late-stage biotechnology company developing next-gen vaccines for serious infectious diseases, has advanced its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19.
WuXi Biologics’ Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader Wuxi Biologics
February 19, 2020
WuXi Vaccines has entered into a strategic partnership with a global vaccine leader and signed a 20-year vaccine manufacturing contract valued approximately $3 billion USD.
Young Adults Who Ever Received HPV Vaccine on the Rise drugs
January 20, 2020
From 2013 to 2018, there was an increase in the percentage of adults aged 18 to 26 years who received one or more doses or the recommended number of doses of human papillomavirus (HPV) vaccine ...
Universal Flu Vaccine Works in Mice drugs
January 16, 2020
An experimental flu vaccine gave mice long-lasting protection against six different flu virus strains, researchers report. The nanoparticle vaccine contains two major influenza proteins -- matrix protein 2 ectodomain (M2e), and neuraminidase (NA) ...
Global neoantigen cancer vaccine market to generate $1,826.1m revenue by 2030 europeanpharmaceuticalreview
January 16, 2020
A study suggests the global neoantigen cancer vaccine market will grow exponentially due to expected drug launches, new technology reducing costs and currently unmet needs of the market.
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints pharmaceutical-business-review
January 14, 2020
VBI Vaccines has reported top-line data from CONSTANT, the second pivotal Phase 3 study, assessing lot-to-lot manufacturing consistency of Sci-B-Vac, the company’s trivalent hepatitis B (HBV) vaccine ...
Internally-developed vaccines reportedly approved in China europeanpharmaceuticalreview
January 09, 2020
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers’ products.
Report indicates seasonal influenza vaccine market in Asia will reach $1bn by 2028 europeanpharmaceuticalreview
January 06, 2020
A new report indicates that drug launches and new formulations will drive the growth of the seasonal influenza vaccine market in China, India and Japan from $914m in 2018 to $1.05bn in 2028.
Intravenous delivery of TB vaccine found to dramatically improve potency in models europeanpharmaceuticalreview
January 03, 2020
New research has shown that intravenous injection of the BCG vaccine dramatically reduces monkey susceptibility to TB bacteria and lung inflammation.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page